SRS Capital Advisors »

Arbutus Biopharma shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Arbutus Biopharma (ABUS) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Arbutus Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arbutus Biopharma held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arbutus Biopharma by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.9k 1.2k 4.81
2024-12-31 $3.9k 1.2k 3.27
2024-09-30 $4.6k 1.2k 3.85
2024-06-30 $3.7k 1.2k 3.09

More positions owned by SRS Capital Advisors

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Eldridge Bbb-b Clo Etf Etf (CLOZ)
Vanguard Index Fds Mid Cap Etf (VO)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
Ishares Tr Ishs 1-5yr Invs (IGSB)
First Tr Exchange Traded Risng Divd Achiv (RDVY)
Schwab Strategic Tr Us Tips Etf (SCHP)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)

View all positions for SRS Capital Advisors

Top funds holding Arbutus Biopharma

Whitefort Capital Management
BlackRock
Two Seas Capital
Vanguard Group
State Street Corporation
ADAR1 Capital Management
Adage Capital Partners GP
Geode Capital Management
Woodline Partners
BlackBarn Capital Partners
Rubric Capital Management
Charles Schwab Investment Management
Advisor Group Holdings
Northern Trust
Stempoint Capital

View all funds holding Arbutus Biopharma